U.S. markets closed

Sophiris Bio, Inc. (SPHS)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0285-0.0025 (-8.06%)
At close: 2:27PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 4/7/2021
Current
Market Cap (intraday) 5
999.69k
Enterprise Value 3
534.69k
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
16.02
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 7
0.69

Trading Information

Stock Price History

Beta (5Y Monthly) 1.50
52-Week Change 3-88.89%
S&P500 52-Week Change 349.51%
52 Week High 30.3300
52 Week Low 30.0100
50-Day Moving Average 30.0306
200-Day Moving Average 30.0215

Share Statistics

Avg Vol (3 month) 3389.15k
Avg Vol (10 day) 377.55k
Shares Outstanding 534.47M
Implied Shares Outstanding 6N/A
Float 32.62M
% Held by Insiders 10.00%
% Held by Institutions 15.42%
Shares Short (Feb 27, 2020) 41.37M
Short Ratio (Feb 27, 2020) 48.61
Short % of Float (Feb 27, 2020) 44.53%
Short % of Shares Outstanding (Feb 27, 2020) 43.96%
Shares Short (prior month Jan 30, 2020) 41.51M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:52
Last Split Date 3Aug 14, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-56.39%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -10.07M
Net Income Avi to Common (ttm)37k
Diluted EPS (ttm)0.0010
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.3M
Total Cash Per Share (mrq)0.18
Total Debt (mrq)5.84M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.79
Book Value Per Share (mrq)-0.08

Cash Flow Statement

Operating Cash Flow (ttm)-10.54M
Levered Free Cash Flow (ttm)-6.83M